Autopsy report · NCT05407831

Lean Diabetes Study

“Per Endocrinology study team, COVID prevented enrollment, and then PI left institution.”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Sponsor

Leon Fogelfeld MD

Sponsor type

Government (non-US federal)

Conditions

Lean Diabetes Mellitus

Interventions

Genetic; Social habits; Perinatal stress

Participants

0

Sites

1

Countries

United States

Trials that died the same way

• Adductor Canal Block (ACB) vs Femoral Nerve Block (FNB) in Revision Total Knee Arthroplasty
  “Was placed on hold due to the COVID-19 pandemic, and then PI decided not to continue study.” (70% match in meaning)
• Changing Developmental Trajectories Through Early Treatment
  “Participant enrollment was hindered by the COVID-19 pandemic and the study was ultimately terminated.” (69% match in meaning)
• Pain Control Without Opioids
  “Enrollment was never initiated and the PI is leaving the institution so the study is closing.” (67% match in meaning)
• Use of Simvastatin for the Prevention of Vasospasm in Aneurysmal Subarachnoid Hemorrhage
  “Study PI left the institution and study was stopped at that time.” (67% match in meaning)
• TDCS-Augmented Prolonged Exposure Therapy
  “Study withdrawn due to delay in recruitment due to COVID-19; the PI also moved to a new institution.” (66% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.